Tata Motors appoints GM's Karl Slym as MD
NEW DELHI/BEIJING (Reuters) - Karl Slym, the executive vice president of one of General Motors' joint ventures in China, left the company after less than a year in the job on Tuesday to join Tata Motors as managing director.
Slym joins Tata Motors at a time when the Indian company has warned about sales at home and amid renewed doubts about the sales outlook for its key Jaguar Land Rover subsidiary.
Slym headed the India operations for General Motors from 2007 until last year and took over as executive vice president at SAIC GM Wuling Automobile Co, GM's joint venture in China that produces no-frills micro-vans, in January.
SAIC GM Wuling is based in Liuzhou in the southern China region of Guangxi. The company sold 686,720 Wuling cars during the first half of this year, up 13.6 percent from the year-ago period.
GM had no issues with Slym's management of the China joint venture, people familiar with the matter said.
Slym, who will take up his new role on October 1, will now lead all Tata Motors operations in India and overseas, although the company's popular luxury unit Jaguar Land Rover will be managed independently, Tata Motors said in a statement on Tuesday.
Slym will succeed P.M. Telang, who retired in June, Tata Motors said. A General Motors statement said it will name a replacement for Slym "at a later date."
Tata Motors, India's biggest truck and bus maker, posted a 3.6 percent fall in vehicle sales for April-June. The India business profit nearly halved to 2.1 billion rupees.
Slym, in his previous India role, was perceived to be media-friendly and is familiar with the country's lucrative low-cost engineering and manufacturing base. He appeared on a television commercial flaunting the "Chevrolet promise."
(Reporting by Anurag Kotoky in NEW DELHI and Norihiko Shirouzu in BEIJING; Editing by Gopakumar Warrier; Editing by Ken Wills)
- Tweet this
- Share this
- Digg this
- Scots spurn independence in historic vote but demand new powers
- PM Modi says al Qaeda will fail in India - CNN
- India TV anchor's number is up after naming China's Xi 'Eleven'
- CORRECTED-UPDATE 2-SAP agrees to buy expense software maker Concur for $7.3 bln
- China not warlike, says Xi, as border standoff dominates India trip
India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority told Reuters on Friday. Full Article
Obama to nominate Indian-American Richard Verma as India ambassador - congressional source. Full Article
Top rice exporter India importing over 100,000 T on temporary supply squeeze. Full Article